Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACADEMIC: A Randomized Phase II Clinical Trial of ADT Combined With Abiraterone or Docetaxel in Metastatic Hormone Sensitive Prostate Cancer

NCT03827473 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT03827473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03827473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACADEMIC: A Randomized Phase II Clinical Trial of ADT Combined With Abiraterone or Docetaxel in Metastatic Hormone Sensitive Prostate Cancer
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Terminated
Start date
February 8, 2019
Completion date
July 31, 2019
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castration-sensitive prostate carcinoma, metastatic prostatic adenocarcinoma, stage iv prostate cancer, stage iva prostate cancer, stage ivb prostate cancer